Search research articles
Contact Us
Filters
Showing results (291-300 of 303) with videos related to
Page
of 31
Sort By:
JAMA Oncology
|
January 2, 2026
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical Trial
Xinan Sheng, Gang Huang, Meiyu Fang, et al.
ACS Infectious Diseases
|
July 30, 2025
GaSal-2: A Water-Soluble Antipseudomonal Agent Targeting the Extracellular Hemophore HasAp
Aziza Frank, Lucia Hwang, William T Witt, et al.
Brain : a Journal of Neurology
|
December 29, 2020
5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy
Jianying Xi, Xilu Wang, Dongyue Yue, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2022
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
Tessa Gargett, Lisa M Ebert, Nga T H Truong, et al.
Stem Cell Research & Therapy
|
December 6, 2014
Human mesenchymal stem cells possess different biological characteristics but do not change their therapeutic potential when cultured in serum free medium
Youwei Wang, Hehe Wu, Zhouxin Yang, et al.
Nature Communications
|
November 9, 2021
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
Nadia El Khawanky, Amy Hughes, Wenbo Yu, et al.
The Journal of Clinical Investigation
|
August 3, 2016
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma
Mariano G Cardenas, Wenbo Yu, Wendy Beguelin, et al.
Clinical & Translational Immunology
|
October 21, 2020
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy
Lisa M Ebert, Wenbo Yu, Tessa Gargett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 4, 2020
Structure of the cell-binding component of the <i>Clostridium difficile</i> binary toxin reveals a di-heptamer macromolecular assembly
Xingjian Xu, Raquel Godoy-Ruiz, Kaylin A Adipietro, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 20, 2023
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2
Rodrigo Lázaro-Gorines, Patricia Pérez, Ignacio Heras-Murillo, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 303) with videos related to
Sort By:
Page
of 31
JAMA Oncology
|
January 2, 2026
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical Trial
Xinan Sheng, Gang Huang, Meiyu Fang, et al.
ACS Infectious Diseases
|
July 30, 2025
GaSal-2: A Water-Soluble Antipseudomonal Agent Targeting the Extracellular Hemophore HasAp
Aziza Frank, Lucia Hwang, William T Witt, et al.
Brain : a Journal of Neurology
|
December 29, 2020
5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy
Jianying Xi, Xilu Wang, Dongyue Yue, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2022
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
Tessa Gargett, Lisa M Ebert, Nga T H Truong, et al.
Stem Cell Research & Therapy
|
December 6, 2014
Human mesenchymal stem cells possess different biological characteristics but do not change their therapeutic potential when cultured in serum free medium
Youwei Wang, Hehe Wu, Zhouxin Yang, et al.
Nature Communications
|
November 9, 2021
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
Nadia El Khawanky, Amy Hughes, Wenbo Yu, et al.
The Journal of Clinical Investigation
|
August 3, 2016
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma
Mariano G Cardenas, Wenbo Yu, Wendy Beguelin, et al.
Clinical & Translational Immunology
|
October 21, 2020
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy
Lisa M Ebert, Wenbo Yu, Tessa Gargett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 4, 2020
Structure of the cell-binding component of the <i>Clostridium difficile</i> binary toxin reveals a di-heptamer macromolecular assembly
Xingjian Xu, Raquel Godoy-Ruiz, Kaylin A Adipietro, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 20, 2023
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2
Rodrigo Lázaro-Gorines, Patricia Pérez, Ignacio Heras-Murillo, et al.
Page
of 31